WHY CHOOSE KESIMPTA
RMS TREATMENT ON YOUR TERMS
KESIMPTA® is the only B-cell treatment you can take just once a month* from the comfort of home—or bring with you.
Designed to be Different
Check out the powerful results† of KESIMPTA
Review the proven safety profile†
Learn about the easy-to-use‡ auto-injector pen
†Proven to reduce relapses and disability progression in 2 studies vs teriflunomide.
‡As seen in a real-world 30-question survey of 105 US patients (aged ≥18) diagnosed with RMS for 1+ years who took KESIMPTA with the auto-injector pen within previous 12 months. On a scale of 1-5, 89.5% of patients rated it a 4 or 5 (5 being most positive) on overall ease of use and ease of monthly dosing schedule. Questionnaire not validated.
WALT D.
Dad, Engineer
Chose KESIMPTA as 1st treatment: 2021
“I have a busy work schedule and an active lifestyle, so being able to take my KESIMPTA treatment at home, on my time, was the right choice for me. My son loves being outdoors and I want to be able to keep up with that, now and in the future.“
Up Next:
Explore the powerful† results of KESIMPTA.
Want more info to help you decide?
Find out why so many people are choosing KESIMPTA.
Want co-pay help?
97% of all prescriptions filled have a $0 out of pocket cost when used with the Access Card.‡‡§§
MS, multiple sclerosis; RMS, relapsing multiple sclerosis.
‡‡Limitations apply. Offer not valid under Medicare, Medicaid, or any other federal or state health insurance program. Patients with commercial insurance who are initially denied coverage may receive free KESIMPTA for up to 12 months while seeking coverage. Patients with commercial insurance who have coverage for KESIMPTA may receive up to $18,000 in annual co-pay benefits. Novartis reserves the right to rescind, revoke, or amend this program without notice. Additional limitations may apply. See complete Terms & Conditions at start.kesimpta.com.
§§2024 data on file.